Abstract
Puromycin treatment of lymphocytes was used to develop a one-way test for leukocyte migration inhibitory factor (LMIF) production in the mixed lymphocyte culture (MLC) reaction. Lymphocytes incubated with this protein synthesis inhibitor induced a vigorous mediator production by nontreated allogeneic cells, being themselves unable to respond to stimulator cells. When puromycin-treated cells were stimulated with the mitogens PHA, ConA, or PWM, overall protein and DNA synthesis were significantly decreased with concomitant abolishment of LMIF production. Viability of stimulator lymphocytes was found to be essential for generation of the mediator in MLC reaction.
Footnotes
-
↵1 This work was supported by grants from National Cancer Institute CA-17404-01, 02 and CA-08748-0851; the Special Fund for the Advanced Study of Cancer; Zelda R. Weintraub Fund; and J.M. Foundation.
- Received March 19, 1976.
- Copyright, 1976, by The Williams & Wilkins Company
- Copyright © 1976 by The American Association of Immunologists, Inc.
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.50
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
Log in using your username and password
In this issue
